Active Ingredient History
Thrombopoietin (THPO) also known as megakaryocyte growth and development factor (MGDF) is a protein that in humans is encoded by the THPO gene. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 1)
Allografts (Phase 3)
Anemia, Aplastic (Phase 4)
Blood Platelet Disorders (Phase 4)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2/Phase 3)
Chemoradiotherapy (Phase 2)
Colorectal Neoplasms (Phase 2)
Drugs, Investigational (Phase 3)
Esophageal Neoplasms (Phase 2)
Hematologic Diseases (Phase 3)
Hematopoietic Stem Cell Mobilization (Phase 1/Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 4)
Inosine Triphosphate (Phase 4)
Leukemia (Phase 1/Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Early Phase 1)
Liver Neoplasms (Phase 1/Phase 2)
Lymphoma (Phase 1/Phase 2)
Multiple Myeloma (Phase 1/Phase 2)
Myeloablative Agonists (Phase 4)
Myelodysplastic-Myeloproliferative Diseases (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Neoplasms (Phase 4)
Neoplasms, Germ Cell and Embryonal (Phase 1/Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Osteosarcoma (Phase 1/Phase 2)
Pharmacokinetics (Phase 4)
Pneumonia (Phase 4)
Pregnancy (Phase 3)
Pregnancy Complications (Phase 2)
Purpura (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Radiation Oncology (Phase 2)
Rhabdomyosarcoma (Phase 1/Phase 2)
Sarcoma (Phase 3)
Sepsis (Phase 2/Phase 3)
Thrombocytopenia (Phase 4)
Thrombopoietin (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue